AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Spanish pharmaceutical giant Grifols (GRFS.US) is in active talks with banks to refinance its 370 million euros of bonds due in 2025 and extend its 1.4 billion euros (about $1.48 billion) revolving credit facility, in a bid to ease investor concerns over its ability to repay its debts, CEO Nacho Abia said in an interview, highlighting the company's need to maintain financial flexibility.
Global insights driving the market strategies of tomorrow.

Sep.28 2025

Sep.27 2025

Sep.26 2025

Sep.26 2025

Sep.26 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet